Amedeo's Top 20

Amedeo Smart

Independent Medical Education


31 October 2022

Multidisciplinary Journal Club

  1. Vogel A, Meyer T, Sapisochin G, Salem R, et al.
    Hepatocellular carcinoma.
    Lancet 2022.

  1. Tsien CI, Pugh SL, Dicker AP, Raizer JJ, et al.
    NRG Oncology/RTOG1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Reirradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma.
    J Clin Oncol 2022.

  2. Hepler C, Weidemann BJ, Waldeck NJ, Marcheva B, et al.
    Time-restricted feeding mitigates obesity through adipocyte thermogenesis.
    Science 2022;378:276-284.

  3. Tao C, Nogueira RG, Zhu Y, Sun J, et al.
    Trial of Endovascular Treatment of Acute Basilar-Artery Occlusion.
    N Engl J Med 2022;387:1361-1372.

  4. Rossing P, Caramori ML, Chan JCN, Heerspink HJL, et al.
    Executive summary of the KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease: an update based on rapidly emerging new evidence.
    Kidney Int 2022;102:990-999.

  1. Planche V, Bouteloup V, Pellegrin I, Mangin JF, et al.
    Validity and Performance of Blood Biomarkers for Alzheimer Disease to Predict Dementia Risk in a Large Clinic-Based Cohort.
    Neurology 2022.

  2. McQuaid JR, Buelt A, Capaldi V, Fuller M, et al.
    The Management of Major Depressive Disorder: Synopsis of the 2022 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline.
    Ann Intern Med 2022;175:1440-1451.

  3. Schiller K, Berrahmoune S, Dassi C, Corriveau I, et al.
    Randomized placebo-controlled crossover trial of memantine in children with epileptic encephalopathy.
    Brain 2022.

  4. LaCasce AS, Dockter T, Ruppert AS, Kostakoglu L, et al.
    Positron Emission Tomography-Adapted Therapy in Bulky Stage I/II Classic Hodgkin Lymphoma: CALGB 50801 (Alliance).
    J Clin Oncol 2022.

  5. Gunst JD, Pahus MH, Rosas-Umbert M, Lu IN, et al.
    Early intervention with 3BNC117 and romidepsin at antiretroviral treatment initiation in people with HIV-1: a phase 1b/2a, randomized trial.
    Nat Med 2022.

  1. Liu ZY, Chen QY, Zhong Q, Li P, et al.
    Intraoperative Adverse Events, Technical Performance, and Surgical Outcomes in Laparoscopic Radical Surgery for Gastric Cancer: A Pooled Analysis from two Randomized Trials.
    Ann Surg 2022.

  2. Snetselaar L, Cheek JJ, Fox SS, Healy HS, et al.
    Efficacy of Diet on Fatigue and Quality of Life in Multiple Sclerosis: A Systematic Review and Network Meta-analysis of Randomized Trials.
    Neurology 2022.

  3. Dawwas GK, Cuker A, Barnes GD, Lewis JD, et al.
    Apixaban Versus Rivaroxaban in Patients With Atrial Fibrillation and Valvular Heart Disease : A Population-Based Study.
    Ann Intern Med 2022.

  4. Johnston C, Magaret A, Son H, Stern M, et al.
    Viral Shedding 1 Year Following First-Episode Genital HSV-1 Infection.
    JAMA 2022.

  5. Yardeni D, Chang KM, Ghany MG.
    Current Best Practice in Hepatitis B Management & Understanding Long-Term Prospects for Cure.
    Gastroenterology 2022.

  1. Kunutsor SK, Hamal PB, Tomassini S, Yeung J, et al.
    Clinical effectiveness and safety of spinal anaesthesia compared with general anaesthesia in patients undergoing hip fracture surgery using a consensus-based core outcome set and patient-and public-informed outcomes: a systematic review and me
    Br J Anaesth 2022;129:788-800.

  2. Slager SL, Parikh SA, Achenbach SJ, Norman AD, et al.
    Progression and survival of MBL: a screening study of 10 139 individuals.
    Blood 2022;140:1702-1709.

  3. Frequin HL, Schouten J, Verschuur CVM, Suwijn SR, et al.
    Levodopa Response in Patients With Early Parkinson Disease: Further Observations of the LEAP Study.
    Neurology 2022.

  4. van Kempen ZLE, Hogenboom L, Toorop AA, Steenhuis M, et al.
    Ocrelizumab concentration is a good predictor of SARS-CoV-2 vaccination response in patients with multiple sclerosis.
    Ann Neurol 2022.

  5. Biegus J, Voors AA, Collins SP, Kosiborod MN, et al.
    Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial.
    Eur Heart J 2022.


more..


Privacy Policy